Humanwell Healthcare Group Co

Humanwell Healthcare Group Co FCF/Debt

The Free Cash Flow to Debt Ratio of Humanwell Healthcare Group Co (600079.SS) as of Nov 16, 2026 is 73.57 %. In the previous year, Free Cash Flow to Debt Ratio was 13.59 % — a change of 441.42% (higher).

FCF/Debt

73.57 %

YoY

441.42%

Last updated:

Free Cash Flow to Debt Ratio of Humanwell Healthcare Group Co is 2025 73.57 % . Free Cash Flow to Debt Ratio of Humanwell Healthcare Group Co was 2024 13.59 % . It decreases by 441.42% higher compared to the previous year.

The Humanwell Healthcare Group Co FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
-6.26 CNY
Jan 1, 2019
10.02 CNY
Jan 1, 2020
6.63 CNY
Jan 1, 2021
3.67 CNY
Jan 1, 2022
-6.56 CNY
Jan 1, 2023
0.09 CNY
Jan 1, 2024
13.59 CNY
Jan 1, 2025
73.57 CNY
The Humanwell Healthcare Group Co FCF/Debt history
YEARFCF/DebtYoY
73.57 %+441.42%
13.59 %+15,036.49%
0.09 %-101.37%
-6.56 %-278.78%
3.67 %-44.69%
6.63 %-33.78%
10.02 %-259.93%
-6.26 %-62.25%
-16.60 %+82.20%
-9.11 %-33.34%
-13.66 %+36.06%
-10.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Humanwell Healthcare Group Co Stock analysis

What does Humanwell Healthcare Group Co do? Humanwell Healthcare (Group) Co., Ltd. generates revenue through the research and development, production, and sale of a diverse portfolio of medical products. The company’s offerings are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines, and others, alongside the provision of medical instruments. This broad product range allows the firm to serve various healthcare needs across its operational scope. The company distributes its products in both domestic market and to overseas markets, indicating a dual-channel sales strategy that captures value from local and international customers. By engaging in the full lifecycle of medical product creation, from R&D to final sale, Humanwell Healthcare (Group) Co., Ltd. monetizes its extensive capabilities and wide distribution network to drive financial performance. Humanwell Healthcare Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humanwell Healthcare Group Co stock

Free Cash Flow to Debt Ratio of Humanwell Healthcare Group Co is 73.57 % in 2025.

Free Cash Flow to Debt Ratio of Humanwell Healthcare Group Co changed from 13.59 % to 73.57 %, representing a 441.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Humanwell Healthcare Group Co since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Humanwell Healthcare Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Humanwell Healthcare Group Co

All Key Metrics — Humanwell Healthcare Group Co